Craft

DXS International

Stock Price

€0

2024-10-29

Revenue

£3.5 M

FY, 2025

DXS International Summary

Company Summary

Overview
DXS International is a healthcare IT company that provides clinical decision-support solutions for clinicians and patients. It offers BestPathway, a communication tool that allows instant access to clinical guidance, treatment pathways, and SMART referral forms and ExpertCare, a medicines optimisation tool for managing hypertension consultations.
Type
Public
Status
Active
Founded
2001
Website
https://www.dxs-systems.co.uk
Cybersecurity rating
Sectors

Table of Contents

DXS International Financials

Summary Financials

Revenue (H1, 2026)
£1.7M
Gross profit (H1, 2026)
£1.5M
Net income (H1, 2026)
(£99.0K)
Cash (H1, 2026)
£160.0K
EBIT (H1, 2026)
(£137.0K)

Footer menu